ACPU
GMED icon

Arrowgrass Capital Partners (US)’s Globus Medical GMED Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-90,000
Closed -$2.27M – 532
2015
Q1 		$2.27M Buy
+90,000
New +$2.19M 0.03% 243

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
KI
Kalmar Investments Greenville, Delaware $443M AUM 23.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s GMED Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of Globus Medical (GMED) in Q2 2015, closing a stake of 90,000 shares — an estimated $2.27M sold.

Arrowgrass Capital Partners (US) first reported a position in GMED in Q1 2015 and held it in 1 quarter. The position peaked at $2.27M in Q1 2015. 180 funds tracked by Wall St. Rank hold GMED as of Q2 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Globus Medical position as of Q2 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 90,000 Globus Medical shares in Q2 2015, an estimated $2.27M.
  • Arrowgrass Capital Partners (US) first reported a position in Globus Medical in Q1 2015 and held it in 1 quarter.
  • Arrowgrass Capital Partners (US)'s Globus Medical position peaked at $2.27M in Q1 2015.
  • 180 funds tracked by Wall St. Rank held Globus Medical as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.